Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
में प्रकाशित: | PLoS One 17(2022)10, S. e0274315 |
---|---|
मुख्य लेखकों: | Hawchar, Fatime (लेखक), Tomescu, Dana (लेखक), Henzler, Dietrich (लेखक) |
स्वरूप: | लेख |
भाषा: | English |
प्रकाशित: |
2022
|
विषय: | |
ऑनलाइन पहुंच: | https://doi.org/10.1371/journal.pone.0274315 |
संबंधित चीजें : | In:
PLoS One |
समान संसाधन
-
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
द्वारा: Köhler, Thomas, और अन्य
प्रकाशित: (2021) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
द्वारा: Köhler, Thomas, और अन्य
प्रकाशित: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
द्वारा: Köhler, Thomas, और अन्य
प्रकाशित: (2021) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
द्वारा: Schultz, Philipp, और अन्य
प्रकाशित: (2021) -
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
द्वारा: Al-Batran, Salah-Eddin, और अन्य
प्रकाशित: (2021)